15 November 2026
Daily Current Affairs — 15 November 2026
WHO issues its first clinical guidelines for adults with type 1 diabetes; three source-verified MCQs.
Science and Public HealthDP Score 82/1001. WHO issues first adult type 1 diabetes guidelines on World Diabetes Day 2026
Read more Read less
What Happened?
On 14 November 2026, World Diabetes Day, the World Health Organization issued its first guidelines on the diagnosis and management of type 1 diabetes in adults. The guidance is intended for health systems including low-resource, emergency and humanitarian settings. This is a WHO clinical guideline, not an Indian law or a claim that diabetes has been cured.
Why It Matters
Type 1 diabetes requires access to insulin and ongoing glucose monitoring. WHO estimates that about 9.5 million people globally lived with type 1 diabetes in 2025 and around 500,000 more were diagnosed that year. The guideline addresses gaps in affordable, continuous care and is relevant to noncommunicable disease management, universal health coverage and humanitarian health services.
Key Exam Facts
- WHO issued its first adult type 1 diabetes diagnosis-and-management guidelines on 14 November 2026.
- WHO recommends multiple daily insulin injections with doses adjusted to blood glucose; human insulin is an appropriate effective option.
- Glucose monitoring may involve finger-prick testing or continuous glucose monitoring; clinic testing can assess average glucose over preceding months.
- WHO targets access to affordable insulin and blood-glucose self-monitoring for all people with type 1 diabetes by 2030.
- WHO estimated about 9.5 million people living with type 1 diabetes worldwide in 2025; the figure is specific to type 1, not all diabetes.
Static–Current Linkage
Type 1 diabetes involves inadequate insulin production and typically requires lifelong insulin treatment; type 2 diabetes commonly involves insulin resistance and/or inadequate insulin secretion. Insulin regulates blood glucose. WHO is a UN specialized agency for international public health. Guidelines inform evidence-based care but do not themselves impose binding legal obligations on countries.
Exam Edge
For CDS/CAPF/NDA/AFCAT, prioritise the pancreas–insulin–blood-glucose relationship, type 1 versus type 2 diabetes, WHO institutional role and public-health access. Avoid treating a clinical guideline as a treaty or confusing the type 1 estimate with total global diabetes prevalence.
Future Question Angles
- Identify the hormone whose deficiency is central to type 1 diabetes.
- Distinguish WHO clinical guidelines from legally binding national regulations.
- Explain why insulin access and glucose monitoring matter for noncommunicable disease management.
Source date: 2026-11-14
World Health OrganizationTest today’s Current Affairs
Which hormone is essential for controlling blood glucose and must be supplied to people with type 1 diabetes when the body produces insufficient amounts?